Global High Level Disinfectants Market
MARKET OVERVIEW:
The global high level disinfectant market was valued at US$ 3.4 billion in 2024 and is projected to reach US$ 4.9 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period (2025-2032).
This growth is primarily driven by increasing healthcare expenditure, rising prevalence of hospitalacquired infections, and stricter regulations regarding infection control. North America currently holds the largest market share at 38.7%, followed by Europe at 28.3% and Asia-Pacific at 21.5%.
MARKET INSIGHT & GROWTH DRIVERS:
CAGR 2032
US$ 3.4 billion US$ 4.9 billion 5.1% Click Here for More Detailed
Market growth is being propelled by accelerating eVTOL prototype developments and regulatory approvals globally.
•Endoscope disinfection
Ultrasonic probe disinfection (22.7%)
MARKET SEGMENTATION:
•Surgical instrument disinfection
APPLICATION Peracetic Acid (38.2% market share) Disinfectant
End user North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
MARKET DYNAMICS
Market Leaders Expand Production Capacities to Meet Growing Regional Demand
The primary driver for the high level disinfectant market is the increasing incidence of hospital-acquired infections (HAIs), which affect 5-10% of hospitalized patients in developed countries. Regulatory requirements such as those from FDA, CDC and WHO are becoming more stringent regarding medical device reprocessing. The global geriatric population has grown by 56% since 2000, driving demand for medical procedures requiring disinfection. Technological advancements in automated endoscope reprocessing systems have increased disinfectant efficiency by 40% compared to
MARKET OPPORTUNITIES
The development of eco-friendly disinfectants represents a $300 million market opportunity through 2030. Emerging Asian markets offer 35-40% higher growth potential than established regions. Single-use disinfectant systems are gaining traction with 22% annual growth potential. The integration of IoT in disinfection monitoring creates opportunities for smart reprocessing solutions worth $150 million. Home healthcare device disinfection represents an underserved $85 million market opportunity in developed countries.
COMPANY MISSION
Boron neutron capture therapy (BNCT) is emerging as a promising cancer treatment modality, particularly for difficult-to-treat tumors like glioblastoma. Japan has led clinical adoption with over 200 patients treated since 2020, while China and Europe are ramping up clinical trials. The precision targeting capability of boron-10, when irradiated with low-energy neutrons, minimizes damage to healthy tissues - a significant advantage over conventional radiotherapy. Pharmaceutical companies are investing in boron-containing drug development, with several boron-10 based compounds currently in Phase II/III trials for various oncology indications.
COMPETITIVE LANDSCAPE
• Steris
• Microbide
• CS Medical
• Metrex
• Advanced Sterilization Products
• Cantel
• SARAYA
• B. Braun
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
About Us
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights
